(+)-VINCRISTINE
Gamma Delta Hepatosplenic T-Cell Lymphoma
Ruijin HospitalSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the Gamma Delta Hepatosplenic T-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine National Cancer Institute (NCI) | Phase 2 | BBB |
PREDNISONE TABLETS City of Hope Medical Center | Phase 4 | BBB |
Inno-206 National Cancer Institute (NCI) | Phase 4 | BBB |
Inno-206 National Cancer Institute (NCI) | Phase 4 | BBB |
Ifosfamide Shandong Provincial Hospital | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →